FARMAKOTERAPIYa V AKUShERSTVE I GINEKOLOGII Primenenie nizkomolekulyarnogo geparina v akusherskoy, ginekologicheskoy i onkologicheskoy praktike
- Authors: Makatsariya A.D1, Bitsadze V.O1, Akin'shina S.V1
-
Affiliations:
- Московская медицинская академия И.М.Сеченова
- Issue: Vol 7, No 7 (2005)
- Pages: 556-565
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/91954
- ID: 91954
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. D Makatsariya
Московская медицинская академия И.М.Сеченова
V. O Bitsadze
Московская медицинская академия И.М.Сеченова
S. V Akin'shina
Московская медицинская академия И.М.Сеченова
References
- Макацария А.Д., Бицадзе В.О. Тромбофилии и противотромботическая терапии в акушерской практике. М.: Триада-Х, 2003.
- Макацария А.Д. Низкомолекулярный гепарин и тромбофилитические состояния в акушерстве. М.: Адаманть, 2002.
- Brenner B. Inheridited thrombophilia and pregnancy loss. Thrombos Haemostas 1999; 82 (2): 634–41.
- Levine M.N, Lee A.E.E. Risk assessment and primary VTE Prevention in the cancer patients. Pathophysiol Haemostas Thrombos 2003; 33 (1): 36–42.
- Levi M. Therapeutic Options in Patients with DIC and cancer. Pathophysiol Haemostas Thrombos 2003; 33 (1): 46–8.
- American College of Chest Physicians (ACCP), the American College of Obstetrics and Gynecology (ACOG), the Obstetric Medical Group of Australasia (OMGA), the Royal College of Obstetricians and Gynaecologists (RCOG), and the Scottish Intercollegiate Guidelines Network (SIGN).
- Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: The LIVE-ENOX study. (Brenner B, Younis J et al, for the LIVE-ENOX Investigators, J Thromb Haemost 2004 1538-7836.2004.01090.x, for February publication.
- Савельев В. С. Послеоперационные ВТЭО: фатальная неизбежность или контролируемая опасность? Хирургия, 1999; 6: 60–5.
- ENOXACAN Study Group (Bergqvist D et al.) Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double - blind randomized multicentre trial with venographic assessment. Brit J of Surg 1997; 84: 1099–103.
- Bergqvist D, Agnelli G, Cohen A.T et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Eng J Med 2002; 346: 975–80.
Supplementary files
